Review



src py 416  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc src py 416
    Src Py 416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2777 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/src py 416/product/Cell Signaling Technology Inc
    Average 96 stars, based on 2777 article reviews
    src py 416 - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    src py 416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc src py 416
    Src Py 416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/src py 416/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    src py 416 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    antibodies against py 416 -src or py 397 and total fak  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc antibodies against py 416 -src or py 397 and total fak
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Antibodies Against Py 416 Src Or Py 397 And Total Fak, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against py 416 -src or py 397 and total fak/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibodies against py 416 -src or py 397 and total fak - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    src py(416) antibody  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc src py(416) antibody
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Src Py(416) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/src py(416) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    src py(416) antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    p src py 416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc p src py 416
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    P Src Py 416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p src py 416/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    p src py 416 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    primary antibodies against src-py 416 , akt-ps 473 , akt cell signalling  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc primary antibodies against src-py 416 , akt-ps 473 , akt cell signalling
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Primary Antibodies Against Src Py 416 , Akt Ps 473 , Akt Cell Signalling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against src-py 416 , akt-ps 473 , akt cell signalling/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against src-py 416 , akt-ps 473 , akt cell signalling - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    anti-py 416 -src antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology anti-py 416 -src antibody
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Anti Py 416 Src Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-py 416 -src antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-py 416 -src antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    mlk3 pjnk src py 416 src  (Cell Signaling Technology Inc)
    93
    Cell Signaling Technology Inc mlk3 pjnk src py 416 src
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Mlk3 Pjnk Src Py 416 Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mlk3 pjnk src py 416 src/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    mlk3 pjnk src py 416 src - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    anti py 416 src  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc anti py 416 src
    Reprehensive image of <t>FAK</t> staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.
    Anti Py 416 Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti py 416 src/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    anti py 416 src - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Reprehensive image of FAK staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.

    Journal: American Journal of Translational Research

    Article Title: Integrin-associated CD151 is a suppressor of prostate cancer progression

    doi:

    Figure Lengend Snippet: Reprehensive image of FAK staining in human prostate tumors. A. TMA from the local prostate cancer patient cohort was subjected to IHC analysis with an FAK-specific antibody. a-f. FAK staining in tumors with benign feature or varying in Gleason grade or stage. Scale: 100×, 200× insert. B. MTT analysis of CD151 knockdown on tumor cell sensitivity to FAK inhibitor (VS-6063) or chemotherapeutic agent (Docetaxel). BPH Tumor cells with or without stable knockdown of CD151 were treated with indicated agents for 72 h, followed by analyses of cell viability by MTT assay and paired t-test analysis. *: p value <0.05; **: p value <0.01. C. FAK deregulation at genomic and mRNA levels and association with oncogenic drivers in the TCGA prostate cancer patient cohort (Cell, 2015). a, b. Association between mRNA expression of FAK and gene copy number. CD151 mRNA expression and Gleason grade. c-e. Plots of FAK mRNA expression and tumor Gleason grade, AR and p53.

    Article Snippet: The antibodies against pY 416 -Src or pY 397 and total FAK were obtained from Cell Signaling Technology (Danver, MA) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively.

    Techniques: Staining, Knockdown, MTT Assay, Expressing